Program Spotlight: The Oregon Breast and Cervical Cancer Program

January is Cervical Health Awareness month, and we are spotlighting a program at the Oregon Health Authority that works on an issue often related to HPV: cervical cancer.

The Oregon Breast and Cervical Cancer Program (BCCP) helps low-income, uninsured, and medically underserved women Oregonians gain access to lifesaving screening programs for early detection of breast and cervical cancers. Each year, approximately 4,000 people in Oregon receive services through the BCCP.

Since the program began in 1995, 71,509 women have received cancer screening, and 56,780 have received clinical services.  Fifty eight invasive cervical cancers have been detected, and 541 have received pre-cancerous cervical diagnoses.

“The BCCP saves lives through screening, early detection, and referral to treatment,” says Kristin Kane, Manager of the program. “Through this program, we can make sure that Oregonians have access to these essential services, regardless of whether they have insurance that covers these services.”

For program eligibility, visit

The BCCP follows the United States Prevention Services Task Force (USPSTF) recommendations for cervical cancer screenings, which consist of the Pap test and high-risk HPV testing.  Women between the ages of 21-64 should receive a Pap smear every 3 years. For women ages 30- 64 who want to lengthen the screening interval, they can be screened with a combination of Pap smear and HPV testing every 5 years.

The BCCP is funded by the Centers for Disease Control and Prevention (CDC), Susan G. Komen for the Cure, Oregon and SW Washington Affiliate, and Oregon State general funds. Also, the BCCP partners with the American Cancer Society to run a patient eligibility hotline.

If you would like to learn more about breast and cervical cancer prevention resources in Oregon, please contact our program at 971-673-0581 or visit

Comments Off on Program Spotlight: The Oregon Breast and Cervical Cancer Program

Filed under Public Health Heroes

Comments are closed.